What is Aviwell?
Founded in France, Aviwell operates as a specialized deep-tech entity focused on the intersection of microbiome science and animal performance. The company's core value proposition lies in its Aneto AI platform, which enables the design of precise bacterial ecologies that function as natural alternatives to traditional antibiotic treatments. By targeting the complex biological needs of poultry and aquaculture, Aviwell addresses the urgent global demand for sustainable, high-performance food production systems. The company's market position is defined by its ability to bridge the gap between advanced computational biology and practical, large-scale agricultural application, effectively positioning itself as a key player in the future of regenerative farming.
How much funding has Aviwell raised?
Aviwell has raised a total of $22.9M across 2 funding rounds:
Angel/Seed
$10M
Series A
$12.9M
Angel/Seed (2023): $10M with participation from Elaia Partners and MFS
Series A (2026): $12.9M led by Hatch Blue, SWEN Capital Partners, and Blast Club
Key Investors in Aviwell
Hatch Blue
Hatch Blue is a global firm dedicated to sustainable growth and innovation in aquaculture, focusing on areas such as regenerative farming, technology innovations, and alternative seafood.
SWEN Capital Partners
SWEN Capital Partners is a responsible investor specializing in private equity, infrastructure, and private debt, focused on creating sustainable value through Tech for Good and Climate Impact initiatives.
Elaia Partners
Elaia is a full stack investor focused on supporting ambitious entrepreneurs from inception to leadership, specializing in backing tech disruptors with a focus on performance and care.
What's next for Aviwell?
With the successful closure of this Series A round, Aviwell is poised to transition from research-heavy development to aggressive market expansion. The strategic allocation of these funds will likely prioritize the scaling of the Aneto AI platform to accommodate broader species applications and the strengthening of its commercial infrastructure. As the global agri-food sector faces increasing regulatory pressure to reduce antibiotic usage, Aviwell's microbiome-based solutions are well-positioned to capture significant market share. Future growth will likely hinge on the company's ability to demonstrate consistent, large-scale efficacy in diverse environmental conditions, further validating its role as a cornerstone of sustainable animal nutrition technology.
See full Aviwell company page
